Related references
Note: Only part of the references are listed.γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
Natasja L. de Vries et al.
NATURE (2023)
A neutrophil response linked to tumor control in immunotherapy
Jeremy Gungabeesoon et al.
CELL (2023)
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
Bastian Kruse et al.
NATURE (2023)
Gene-based delivery of immune-activating cytokines for cancer treatment
Federico Rossari et al.
TRENDS IN MOLECULAR MEDICINE (2023)
IFN? is a central node of cancer immune equilibrium
Michael J. Walsh et al.
CELL REPORTS (2023)
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity
Morgane Boulch et al.
NATURE CANCER (2023)
Once upon a prime: DCs shape cancer immunity
Maria Zagorulya et al.
TRENDS IN CANCER (2023)
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
Raphael Genolet et al.
CELL REPORTS METHODS (2023)
GD2-CART cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G. Majzner et al.
NATURE (2022)
Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic Cells
Christina Pfirschke et al.
CANCER IMMUNOLOGY RESEARCH (2022)
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization
Alycia Gardner et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
CAR T cell killing requires the IFN gamma R pathway in solid but not liquid tumours
Rebecca C. Larson et al.
NATURE (2022)
Dendritic cell cross-dressing and tumor immunity
Amaia Martinez-Usatorre et al.
EMBO MOLECULAR MEDICINE (2022)
Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
Guilan Shi et al.
PHARMACEUTICS (2022)
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models
Filippo Birocchi et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Interferon-γ: teammate or opponent in the tumour microenvironment?
Angela M. Gocher et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Dendritic Cells Revisited
Mar Cabeza-Cabrerizo et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
Tumor-infiltrating dendritic cell states are conserved across solid human cancers
Genevieve M. Gerhard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Isolation and characterization of extracellular vesicle subpopulations from tissues
Rossella Crescitelli et al.
NATURE PROTOCOLS (2021)
CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi et al.
STEM CELL RESEARCH & THERAPY (2021)
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
Johanna Bodder et al.
FRONTIERS IN IMMUNOLOGY (2021)
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis
Sabina Kaczanowska et al.
CELL (2021)
Disentangling the complexity of tumor-derived extracellular vesicles
Tim Beltraminelli et al.
CELL REPORTS (2021)
Platinum Complexes in Colorectal Cancer and Other Solid Tumors
Beate Koeberle et al.
CANCERS (2021)
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
Samarth Hegde et al.
CANCER CELL (2020)
IL-12 from endogenous cDC1, and not vaccine DC, is required for Th1 induction
DiyaaElDin Ashour et al.
JCI INSIGHT (2020)
Antitumour dendritic cell vaccination in a priming and boosting approach
Alexandre Harari et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular Carcinoma
Pedro Molina-Sanchez et al.
GASTROENTEROLOGY (2020)
Umbilical Cord Blood Transplants: Current Status and Evolving Therapies
Ashish O. Gupta et al.
FRONTIERS IN PEDIATRICS (2020)
SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA
Ruiyan Wu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Linda Hammerich et al.
NATURE MEDICINE (2019)
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta et al.
CANCER DISCOVERY (2019)
Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles
Chiara Cianciaruso et al.
CELL REPORTS (2019)
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2019)
Engineering dendritic cell vaccines to improve cancer immunotherapy
Caleb R. Perez et al.
NATURE COMMUNICATIONS (2019)
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
Wouter Scheper et al.
NATURE MEDICINE (2019)
IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression
Hussein F. Aqbi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
EVIR: chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens
Mario Leonardo Squadrito et al.
NATURE METHODS (2018)
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade
Natalie J. Neubert et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
Vassilis Genoud et al.
ONCOIMMUNOLOGY (2018)
CSF1R regulates the dendritic cell pool size in adult mice via embryo-derived tissue-resident macrophages
Gulce Itir Percin et al.
NATURE COMMUNICATIONS (2018)
Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
Thomas Kammertoens et al.
NATURE (2017)
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS
Detian Yuan et al.
CANCER CELL (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
Caroline Baer et al.
NATURE CELL BIOLOGY (2016)
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma
Stefani Spranger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Interleukin-12: Functional activities and implications for disease
Sebastian Zundler et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c+MHCII+ Macrophages and Dendritic Cells
Julie Helft et al.
IMMUNITY (2015)
Defining human dendritic cell progenitors by multiparametric flow cytometry
Gaelle Breton et al.
NATURE PROTOCOLS (2015)
Batf3-dependent CD103(+) dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice
Maria Martinez-Lopez et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow
Christian Thomas Mayer et al.
BLOOD (2014)
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Brian Ruffell et al.
CANCER CELL (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer
Darjus F. Tschaharganeh et al.
CELL (2014)
Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal
Iman Fares et al.
SCIENCE (2014)
Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression
Giulia Escobar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Genetic Tracing via DNGR-1 Expression History Defines Dendritic Cells as a Hematopoietic Lineage
Barbara U. Schraml et al.
CELL (2013)
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Karolina Palucka et al.
IMMUNITY (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells
Brian T. Edelson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
Michael A. Curran et al.
CANCER RESEARCH (2009)
Interleukin-12 is sufficient to promote antigen-independent interferon-gamma production by CD8 T cells in old mice
Erin K. Rottinghaus et al.
IMMUNOLOGY (2009)
Clonotype Selection and Composition of Human CD8 T Cells Specific for Persistent Herpes Viruses Varies with Differentiation but Is Stable Over Time
Emanuela M. Iancu et al.
JOURNAL OF IMMUNOLOGY (2009)
Tumor-targeted interferon-α delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis
Michele De Palma et al.
CANCER CELL (2008)
Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells
M De Palma et al.
NATURE MEDICINE (2003)
Safety of retroviral gene marking with a truncated NGF receptor
C Bonini et al.
NATURE MEDICINE (2003)
Share Paper
